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Objective: While adolescent anxiety dis-
orders represent prevalent, debilitating
conditions, few studies have explored
their brain physiology. Using event-re-
lated functional magnetic resonance im-
aging (fMRI) and a behavioral measure of
attention to angry faces, the authors eval-
uated differences in response between
healthy adolescents and adolescents with
generalized anxiety disorder.
Method: In the primary trials of interest,
18 adolescents with generalized anxiety
disorder and 15 comparison subjects of
equivalent age/gender/IQ viewed angry/
neutral face pairs during fMRI acquisition.
Following the presentation of each face
pair, subjects pressed a button to indicate
whether a subsequent asterisk appeared
on the same (congruent) or opposite (in-
congruent) side as the angry face. Reac-
tion time differences between congruent
and incongruent face trials provided a
measure of attention bias to angry faces.
Results: Relative to the comparison sub-
jects, patients with generalized anxiety
disorder manifested greater right ventro-
lateral prefrontal cortex activation to trials
containing angry faces. Patients with gen-
eralized anxiety disorder also showed
greater attention bias away from angry
faces. Ventrolateral prefrontal cortex acti-
vation differences remained evident when
differences in attention bias were covar-
ied. Finally, in an examination among pa-
tients of the association between degree
of anxiety and brain activation, the au-
thors found that as ventrolateral prefron-
tal cortex activation increased, severity of
anxiety symptoms diminished.
Conclusions: Adolescents with general-
ized anxiety disorder show greater right
ventrolateral prefrontal cortex activation
and attentional bias away from angry
faces than healthy adolescents. Among pa-
tients, increased ventrolateral prefrontal
cortex activation is associated with less se-
vere anxiety, suggesting that this activation
may serve as a compensatory response.
(Am J Psychiatry 2006; 163:1091–1097)
Adolescent generalized anxiety disorder predicts high
risk for adult generalized anxiety disorder, social phobia,
and major depressive disorder (1). While only one study (2)
has explored neurophysiological correlates of generalized
anxiety disorder in youth, considerable data in both the ba-
sic sciences and adult anxiety disorder literature form the
basis for hypotheses about the roles of specific neural struc-
tures in adolescent generalized anxiety disorder (3–12).
Basic research implicates a neural circuit that includes the
amygdala and ventral prefrontal cortex in threat monitoring
and response (5, 9, 10). The ventral prefrontal cortex (in par-
ticular the ventrolateral prefrontal cortex) modulates
amygdala engagement to facilitate flexible attention and be-
havior when responding to environmental threats (3–6, 9).
Anxiety disorders may relate to perturbations in this ventral
prefrontal cortex-amygdala circuit. The only available study
of anxious youth selectively imaged the amygdala in 10 pa-
tients and 10 comparison subjects and reported that pa-
tients showed greater response to threat-related facial ex-
pressions (2). Among adults, patients with anxiety disorders
have shown increased amygdala activation and abnormal
ventral prefrontal cortex responses (8, 12–15). These neural
abnormalities may disrupt the regulatory processes of vigi-
lance and attention to threat-related stimuli.
Increased vigilance and perturbed attention are promi-
nent features of pediatric and adult anxiety disorders (16–
23). Thus, brain-based differences between anxious pa-
tients and comparison subjects may reflect anxiety-re-
lated differences in attentional processes. For example, in
contrast with healthy subjects, anxious patients may shift
attention away from threatening stimuli, which could ei-
ther reflect or affect between-group differences in brain
activation. Therefore, when examining between-group
differences in neural responses, it may be advantageous to
monitor attention and examine effects of attention on be-
tween-group differences in activation.
The visual task used in this study provides an index of
threat-related perturbations in attention (16, 17, 20–22). In
previous studies that used this task, adult patients with
generalized anxiety disorder and other anxiety disorders
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orient attention toward angry faces (i.e., the “threat”)
more strongly than healthy adults (21–23). It is interesting
that in a study of children with posttraumatic stress disor-
der (PTSD), the visual task findings were opposite to those
in adults: pediatric patients displayed a greater attentional
bias away from threat, in comparison with healthy chil-
dren (16). While preliminary, these findings suggest that
anxiety disorders may involve systematic disruptions in
threat biases that vary across development.
For the present functional magnetic resonance imaging
(fMRI) investigation, we used the visual task to examine
differences between adolescents with generalized anxiety
disorder and healthy adolescents. Consistent with prior
studies, we hypothesized that adolescents with general-
ized anxiety disorder would show abnormal ventral pre-
frontal cortex activation and increased amygdala activa-
tion relative to healthy comparison subjects in response to
angry faces. We also hypothesized that adolescents with
generalized anxiety disorder would exhibit abnormal at-
tentional bias to angry faces.
Method
Participants
Thirty-three adolescents participated in this study. Health and
cognitive status of all participants was determined with a physical
examination and an IQ test. The Schedule for Affective Disorders
and Schizophrenia (K-SADS) was administered by trained clini-
cians. Based on an independent study, each clinician had been
shown to have excellent reliability (kappa >0.75) with senior clini-
cians for all diagnoses. Demographic characteristics for all study
subjects are provided in Table 1. The NIMH Institutional Review
Board approved all procedures, and all adolescents/parents pro-
vided written assent/consent.
The primary inclusion criterion was a diagnosis of generalized
anxiety disorder in an adolescent (age 9–17 years); the general-
ized anxiety disorder diagnosis had to be the explicit focus of
treatment. Other inclusion criteria were similar to those in pub-
lished studies of pediatric anxiety disorders (24–26). Specifically,
these included 1) clinically significant symptoms of anxiety (Pedi-
atric Anxiety Rating Scale [27] score ≥10); 2) Children’s Global As-
sessment Scale score <60; 3) desire for outpatient treatment; and
4) persistent anxiety (consistent Pediatric Anxiety Rating Scale
score over a 3-week period during which supportive psychoedu-
cational therapy was provided).
Exclusion criteria were 1) current use of any psychoactive sub-
stance (for patients, usage of any psychoactive substance since
the onset of the anxiety disorder); 2) current Tourette’s syndrome,
obsessive-compulsive disorder, PTSD, conduct disorder, expo-
sure to extreme trauma, or suicidal ideation; 3) lifetime history of
mania, psychosis, or pervasive developmental disorder; or 4)
IQ<70. Major depressive disorder was not considered exclusion-
ary, since longitudinal and family-based studies have noted
strong relationships between adolescent generalized anxiety dis-
order and major depressive disorder. Secondary fMRI analyses
compared activation between groups with and without major de-
pressive disorder as well as social phobia to determine the degree
to which comorbidity moderated findings in patients with gener-
alized anxiety disorder.
Visual Task
We used the same procedures and stimuli as previously de-
scribed (28) (Figure 1). In brief, the trials began with a 500-msec
central fixation point. Two faces then appeared for 500 msec.
These were replaced by an asterisk in one hemi-field for 1100
msec. Participants were instructed to press one button with their
thumb if the asterisk appeared on the left or a second button with
their index finger if the asterisk appeared on the right. The inter-
trial interval was 1900 msec. Before scanning, participants were
trained on the task.
Participants saw 80 actors, each presented twice, for a total of
160 trials (Figure 1). An additional 40 blank trials (no faces and
no asterisks) were presented to serve as the primary comparison
for documenting between-group differences in activation to the
angry faces.
For the behavioral measure of attention, there were two condi-
tions of interest: 1) congruent trials, in which an angry/neutral
face pair was followed by an asterisk on the same side on which
the angry face had appeared; and 2) incongruent trials, in which
an angry/neutral face pair was followed by an asterisk on the
same side on which the neutral face had appeared. Three other
control conditions were included: happy/neutral face pair con-
gruent trials, happy/neutral face pair incongruent trials, and neu-
tral/neutral face pairs. There were 32 trials for each of the five
conditions. Trial presentation order was randomly determined
for each subject. Equal numbers of replicates displayed the emo-
tional face on right and left hemi-fields.
The task was programmed by using E-Prime versions 1.0 and
1.1 by Psychological Software Tools (Pittsburgh, Pa.) and was
displayed on Avotec Silent Vision Glasses (Stuart, Fla.). The but-
ton response system was developed by MRI Devices (Wauke-
sha, Wisc.).
TABLE 1. Demographic and Clinical Characteristics of Adolescents With Generalized Anxiety Disorder and a Comparison
Group of Healthy Adolescents 
Variable
Healthy Group 
(N=15)
Patient Group 
(N=18)
N % N %
Gender
Male 7 46.7 10 55.6
Female 8 53.3 8 44.4
Comorbid diagnoses
Major depressive disorder 0 0.0 9 50.0
Social phobia 0 0.0 10 55.6
Separation anxiety disorder 0 0.0 8 44.4
Mean SD Mean SD
Age 13.53 2.41 12.28 2.05
IQ 115.13 9.77 109.00 12.65
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Functional MRI Procedures and Analyses
Imaging took place over approximately a 1-year period. We
used a GE 3T scanner to acquire images with 29 contiguous 3.3-
mm axial slices parallel to the anterior commissure/posterior
commissure line. We used echo-planar, single-shot gradient echo
T2* weighting (TR=2300 msec; TE=23 msec; field of view=240
mm; 64×64 matrix; 3.3×3.75×3.75 mm voxel). High-resolution T1-
weighted volumetric scans used a magnetization-prepared gradi-
ent echo sequence (MP-RAGE): 180 1.0-mm axial slices; field of
view=256 mm; number of excitations=1; TR=11.4 msec; TE=4.4
msec; matrix=256×256; TI=300 msec; bandwidth 130 Hz/pixel=33
kHz for 256 pixels; in-plane resolution=1 mm3.
Functional imaging data were analyzed using AFNI software
version 2.56b (available at http://afni.nimh.nih.gov/afni) (29).
Participants were excluded if there was movement greater than 2.5
mm in any direction. Movement was mitigated by registering the
images to one volume in each run. Subject data were smoothed
with a 6-mm full width at half maximum isotropic Gaussian filter.
Incorrect trials and trials in which the reaction time for the button
response was <200 msec or >800 msec were removed from the
fMRI analysis.
A random effects fMRI data analysis was conducted by using a
two-level procedure. At the first (subject) level, data from each
subject were separately submitted to multiple regression analyses
using the 3dDeconvolve module in AFNI. For the five conditions
(angry/neutral congruent, angry/neutral incongruent, happy/
neutral congruent, happy/neutral incongruent, and neutral/neu-
tral), five vectors were created containing the onset time of each
trial for each condition (blank trials were modeled as an implicit
baseline). Time points for trials in which the subject responded
incorrectly or did not respond were placed in a separate vector in-
cluded in the multiple regression model as a nuisance covariate.
Using a gamma variate (30), vectors of stimulus timing were
transformed into reference waveforms of response function for
multiple regression, and coefficients were produced for each con-
dition from each subject. Comparison of coefficients for given
conditions yielded contrast values. The primary effect of interest
for the fMRI analysis was response to angry faces. Therefore, con-
trasts were established to examine activation to angry faces rela-
tive to baseline. Before individual subject data sets were sub-
jected to a group level analysis, individual anatomical data sets
were converted to Talairach space. The underlying transforma-
tion was then applied to that same individual’s functional data in
order to convert those images as well. The second (group) level
analysis involved conducting a regression analysis using the AFNI
module 3DregAna on the main contrast of interest: angry versus
baseline trials to evaluate the neurophysiological response with
age as a covariate following previous work (16). For comparison,
we used the same procedures to examine responses to happy
faces versus baseline and neutral faces versus baseline.
We employed two thresholds to evaluate the fMRI results. For
the first threshold, we used the standard whole-brain p<0.001 two-
tailed t test uncorrected for multiple comparisons throughout the
brain (31). As a second step if activation in an area was significant
at p<0.001, we also used a Monte Carlo simulation (32) to sepa-
rately control for multiple comparisons within the primary areas
of interest, the ventral frontal area (anterior to anterior commis-
sure and ventral to genu of corpus callosum) and the amygdala. In
the Monte Carlo simulation, the threshold for considering a given
voxel significant was p<0.01. All voxels within the ventral frontal
area that reached this level of significance were included in the
Monte Carlo simulation. For the overall Monte Carlo simulation,
we used the p<0.05 level for statistical significance.
Behavioral Data Analysis
The same deviant trials were removed as in the fMRI analysis.
Participants were excluded from data analysis if fewer than 75%
of the responses were correct or within the accepted reaction
time range.
Attentional bias scores reflected the difference between mean
reaction times for incongruent and congruent trials, such that
FIGURE 1. Visual Tasks Presented During fMRI Acquisition to Adolescents With Generalized Anxiety Disorder and a Com-
parison Group of Healthy Adolescentsa
a The only difference between the two trials is the location of the probe relative to the threat. For congruent trials, the asterisk (the “probe”)
following the presentation of the angry/neutral face pair was on the same side on which the angry face (the “threat”) had appeared. For in-
congruent trials, the asterisk was on the same side on which the neutral face had appeared. The same actor always modeled the two expres-
sions in the face pair. Trials with happy/neutral and neutral/neutral face pairs were also conducted.
+
*
+
*
Incongruent Trials Congruent TrialsDuration
(msec)
Event
500 Fixation
500 Threat
1100
Probe
(button press)
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positive values indicate bias toward angry faces and negative val-
ues indicate bias away from angry faces (16, 22). A comparable
analysis examined bias for happy faces. An analysis of variance
with age entered as a covariate was used to compare group differ-
ences in attentional bias, following previous work (16) and to be
consistent with the fMRI analysis.
Results
The primary fMRI and behavioral analyses examined
whether there were fMRI activation and reaction time dif-
ferences between the generalized anxiety disorder and
comparison groups in response to angry faces. In addition,
we compared activation between groups for responses to
happy and neutral faces. Secondary analyses evaluated the
degree to which differences in the primary analysis were
influenced by either task performance or comorbidity.
Activation Results
Differential activation between the groups was exam-
ined for the contrast of angry faces versus baseline. In this
analysis, generalized anxiety disorder adolescents showed
greater activation in the right ventrolateral prefrontal cor-
tex (t=3.91, df=30, p<0.001) (Figure 2). The Monte Carlo
simulation was significant at p<0.05 corrected for multiple
comparisons of the region of interest. No effects in the
amygdala were found. No significant differences in activa-
tion were found between the two groups in response to ei-
ther happy or neutral faces relative to baseline.
Behavioral Results
Adolescents with generalized anxiety disorder, relative
to comparison subjects, showed a greater attentional bias
away from angry faces (F=4.90, df=1, 30, p<0.05). For pa-
tients, attentional bias was –6.93 msec (SD=32.3), and for
the healthy subjects the bias was 10.41 msec (SD=21.0).
Mean reaction times for patients were 562.4 msec (SD=
55.0) to angry/neutral congruent trials and 555.5 msec
(SD=53.2) to angry/neutral incongruent trials. Mean reac-
tion times for healthy subjects were 523.8 msec (SD=89.9)
to angry/neutral congruent trials and 534.1 msec (SD=
91.4) to angry/neutral incongruent trials. No between-
group differences were found in reaction time overall to
trials containing angry faces. Furthermore, there were no
between-group differences in attention bias to happy
faces, and there were no between-group differences in re-
action time overall to trials with happy faces.
Secondary Activation Results
Given that there were behavioral differences in atten-
tional bias between groups, a secondary fMRI analysis
included the attentional bias measure as a covariate. In
this analysis, the generalized anxiety disorder group con-
tinued to show greater activation in the previously iden-
tified right ventrolateral prefrontal cortex region (t=3.78,
df=29, p<0.001).
Nine generalized anxiety disorder patients had major
depressive disorder, and nine had no history of major de-
pressive disorder. We examined differences in ventrolat-
FIGURE 2. Ventrolateral Prefrontal Cortex Activation in Healthy Adolescents and Adolescents With Generalized Anxiety Dis-
order by Depressive Comorbidity and Anxiety Symptom Severitya
a Coordinates (x, y, z) are 40, 34, and  –12.
b Blood oxygen level-dependent signal response in the right ventrolateral prefrontal cortex of the generalized anxiety disorder patients was in-
versely correlated with severity of anxiety symptoms (r=–0.55, df=16, p<0.05). 
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eral prefrontal cortex activation from healthy comparison
subjects separately in these two groups and relative to one
another. In order to maximize the likelihood that differ-
ences would be detected between the generalized anxiety
disorder and generalized anxiety disorder/major depres-
sive disorder groups, we used uncorrected t tests and the
values from the ventrolateral prefrontal cortex cluster
analysis presented in Figure 2. Relative to the healthy
comparison subjects, greater ventrolateral prefrontal cor-
tex activation was seen in the generalized anxiety disorder
adolescents either with major depressive disorder (t=4.22,
df=22, p<0.001) or without major depressive disorder (t=
2.89, df=22, p<0.01). No differences in ventrolateral pre-
frontal cortex activation was found between the two pa-
tient groups (t=0.59, df=16, p=0.57).
Furthermore, 10 of the 18 generalized anxiety disorder
patients had social phobia. To evaluate the effect of social
phobia on ventrolateral prefrontal cortex activation, we
employed the same liberal cluster analysis as described
with major depressive disorder to maximize the likelihood
of finding differences. Relative to the healthy comparison
subjects, greater ventrolateral prefrontal cortex activation
was seen in the generalized anxiety disorder adolescents
either with social phobia (t=3.22, df=21, p<0.01) or without
social phobia (t=3.70, df=23, p<0.01). No differences in
ventrolateral prefrontal cortex activation were found be-
tween the two patient groups (t=0.35, df=16, p=0.73).
Finally, to examine the relationship between severity of
anxiety symptoms and brain activation, we entered the
patients’ Pediatric Anxiety Rating Scale scores in a covari-
ate analysis. Results revealed a significant activation in the
right ventrolateral prefrontal cortex (t=3.98, df=16, p=
0.001) (Figure 2). As ventrolateral prefrontal cortex activa-
tion increased across patients, severity of anxiety symp-
toms diminished.
Discussion
In response to angry faces, adolescents with generalized
anxiety disorder, relative to healthy adolescents, exhibited
greater activation in the right ventrolateral prefrontal cor-
tex. Furthermore, adolescents with generalized anxiety
disorder showed an attentional bias away from angry faces
relative to healthy adolescents. When the difference in at-
tention was treated as a covariate in the fMRI analysis, the
generalized anxiety disorder patients continued to show
greater ventrolateral prefrontal cortex activation relative
to comparison subjects, suggesting that differences in at-
tention did not fully account for differences in ventrolat-
eral prefrontal cortex engagement. Contrary to our hy-
pothesis, patients with generalized anxiety disorder did
not evidence greater amygdala activation than healthy
subjects in response to angry faces. Finally, there were no
differences in response to happy or neutral faces.
Abnormal activation in the ventrolateral prefrontal cor-
tex of adolescents with generalized anxiety disorder in the
current study is consistent with previous neuroimaging
work on adults with various anxiety disorders, including
social phobia, PTSD, and panic disorder (7, 12, 13, 33), al-
though the direction of the effects in previous studies is in-
consistent. In the present study, the enhanced generalized
anxiety disorder ventrolateral prefrontal cortex activation
suggests one of two possibilities: a disturbance in func-
tioning that may be a direct neural correlate of increased
anxiety, or a compensatory response designed to regulate
abnormal function in another region.
Support for the first possibility comes from a study of
pediatric patients with traumatic brain injury (34). This
work revealed that greater damage to the ventral prefron-
tal cortex was associated with reduced anxiety, suggesting
that this region is involved in the manifestation of anxiety
symptoms. In the present study, angry faces may have in-
duced a modicum of anxiety among patients, manifested
as increased ventrolateral prefrontal cortex activation.
Concerning the second possibility, the ventral prefrontal
cortex is involved in various regulatory processes (9, 35,
36). In particular, animal work has demonstrated extensive
connections between the ventral prefrontal cortex and
subcortical structures, including the striatum, amygdala,
and hippocampus, which are implicated in processing
emotion-based information (37–39). Moreover, these con-
nections facilitate ventral prefrontal cortex regulation of
subcortical structures (36, 37). Similarly, imaging studies
have suggested that the ventrolateral prefrontal cortex reg-
ulates activation in subcortical structures in adult humans
as well (9, 40, 41). Thus, it is possible that the ventrolateral
prefrontal cortex in the patients modulates abnormal acti-
vation in another region. Differential between-group acti-
vation in the other region was not detected, possibly be-
cause the ventrolateral prefrontal cortex is effectively
modulating the abnormal response. The finding that in-
creased ventrolateral prefrontal cortex activation is associ-
ated with fewer anxiety symptoms is consistent with the
possibility that the activation is compensatory. Enhanced
ventrolateral prefrontal cortex activation may help gener-
alized anxiety disorder patients more effectively regulate
initial responses to anxiety-provoking stimuli, thereby re-
ducing severity of symptoms.
The observation of greater attentional bias away from
threat in adolescent anxiety disorders replicates previous
work in children with PTSD (16). Both the current and the
prior study document findings opposite from those found
in adults. Specifically, in adults studied with the same task,
anxiety disorder patients exhibit a bias toward threat faces
relative to neutral faces, compared with healthy adults (21,
22). Thus, the relationship between anxiety and threat bias
assessed with this task varies across development. An im-
portant direction for future work will be to uncover the
mechanisms that explain the developmental variation.
Monitoring eye gaze, varying intensity of threat, and ma-
nipulating presentation duration may illuminate the vari-
ables that contribute to the developmental differences.
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The current findings illustrate the importance of behav-
ioral measures and event-related analyses in neuroimag-
ing investigations of between-group differences. We re-
stricted our analyses to events in which participants
performed the task properly. Thus, only trials in which
participants were engaged in the task were included in the
analyses. Furthermore, because this task provides a mea-
sure of attention to angry faces, it was possible to evaluate
whether the fMRI results were influenced by group differ-
ences in attention allocation to the angry faces. When the
attentional bias measure was included in the fMRI analy-
sis as a covariate, the between-group difference in ventro-
lateral prefrontal cortex activation remained significant,
indicating that attention differences do not fully account
for these findings.
A potential limitation of this study is that the clinical
group included generalized anxiety disorder patients with
comorbid major depressive disorder or social phobia. To
examine whether effects were differentially influenced by
these other conditions, we examined the ventrolateral
prefrontal cortex activation within each of the clinical
groups. Whereas both clinical subgroups showed signifi-
cantly increased ventrolateral prefrontal cortex activation
relative to healthy subjects in response to angry faces, the
ventrolateral prefrontal cortex activation did not differ be-
tween clinical subgroups. These analyses suggest that the
ventrolateral prefrontal cortex activation was not dispro-
portionately influenced by major depressive disorder or
social phobia.
A second limitation of the study is the broad age range
in our relatively small group, which precluded perfor-
mance of an adequately powered analysis of effects across
development within adolescents. Replication in larger
groups of younger and older adolescents will help to clar-
ify the developmental progression of these findings and
how they relate to anxiety.
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